According to the latest study on “ePRO, ePatient Diaries, and eCOA Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type of Solution, Modality, and End User,” the market was valued at US$ 1,342.92 million in 2020 and it is projected to reach US$ 4,130.35 million by 2028; it is expected to grow at a CAGR of 15.1% during 2021–2028. The report highlights trends prevailing in the market and the factors driving and restraining the market growth.

The usage of electronic Clinical Outcome Assessment (eCOA) is a push toward adapting the ‘new normal’ as it is a method to gather patient data electronically by using technologies such as smart home devices, handheld monitors, wearables, e-diaries, tablets, and web servers to allow the stakeholders (patients, healthy volunteers, investigators and caregivers) in the trials to report outcomes directly and digitally. Although historically COA was only related to the evaluation of Patient-Related Outcomes (PRO), the FDA has now broadened the definition to include PerfO, ClinRO, and ObsRO along with PRO. In simple terms, when the above parameters are reported electronically, they fit under the eCOA spectrum.

Download Sample PDF @  https://bit.ly/3eaFVXX

eCOA/ePRO platform has substantial benefits for sponsors and CROs, as it reduces administrative burden, mitigates cost, and fastens trials. Such system shows strong results with fewer errors and discrepancies, improved data quality, clearer signals, and standardized accurate studies. The factors such as the increasing adoption of EHR and government regulations mandating the maintenance of health records drive the growth of the ePRO, epatient diaries, and eCOA market.

ePRO, epatient diaries, and eCOA market Segmentation :

Based on modality, the ePRO, epatient diaries, and eCOA market is bifurcated into computer and mobile devices. The mobile devices segment held a larger share of the market in 2020. Also, the same segment is estimated to register a higher CAGR in the market during the forecast period.

Bracket Global LLC (Signant Health), CRF Health, Inc., ERT Clinical, Medidata Solutions, Inc., ArisGlobal LLC, Health Diary, Pte., Ltd., ICON Plc, PAREXEL International Corporation , OmniComm Systems, Inc., Kayentis, and eClinical Solutions LLC. are among the major companies operating in the global ePRO, epatient diaries, and eCOA market.

The report segments global ePRO, epatient diaries, and eCOA market as follows:

 By Type of Solution

·  eClinical Outcome Assessments

·         ePatient Reported Outcomes

·         Clinician Reported Outcomes

·         Observer Reported Outcomes

·         Performance Outcomes

·         ePatient Diaries

By Modality

·         Computer

·         Mobile Devices

By End User

·         Clinical Trial Sponsors

·         Contract Research Organizations

Medidata Solutions, Inc. and CRF Health, Inc.- Notable Market Players in ePRO, ePatient Diaries, and eCOA Market

The usage of electronic Clinical Outcome Assessment (eCOA) is a push towards adapting to the ‘new normal’ as it is a method to gather patient data electronically through the use of technology such as smart home devices, handheld monitors, wearables, e-diaries, tablets and web servers to allow the stakeholders in the trials (patients, healthy volunteers, investigators and caregivers) to report outcomes directly and digitally. Although historically COA was only related to the evaluation of Patient-Related Outcomes (PRO), the FDA has now broadened the definition to include PerfO, ClinRO and ObsRO along with PRO. In simple terms, when the above parameters are reported electronically, they fit under the eCOA spectrum.

eCOA/ePRO platform has substantial benefits for sponsors and CROs, as it reduces administrative burden, mitigates cost, and speeds trials. Such a system shows strong results with fewer errors and discrepancies, improved data quality, clearer signals, and standardized, accurate studies. The increasing adoption of EHR, and government regulations mandating maintain health records is driving the growth of the market.

Market leaders operating in the market have undertaken various organic growth strategies in the ePRO, ePatient diaries, and eCOA Market. The ePRO, ePatient diaries, and eCOA market majorly consists of the players including. Bracket Global LLC (Signant Health), CRF Health, Inc., ERT Clinical, Medidata Solutions, Inc., ArisGlobal LLC, Health Diary, Pte., Ltd., ICON Plc, PAREXEL International Corporation, OmniComm Systems, Inc., Kayentis, and eClinical Solutions LLC. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the companies have utilized inorganic strategies including mergers & acquisitions, partnership, and collaborations.

Below is the list of the growth strategies done by the players operating in the ePRO, ePatient diaries, and eCOA market

Feb-21: ERT, announced a powerful new solution for enabling the collection, processing and analysis of photos and audio as part of clinical trial eCOA assessments. This solution promises to streamline and drive patient compliance with data collection, while safeguarding patient privacy, confidentiality and data security.

Mar-21: Signant Health has launched an eCOA solution designed for oncology studies which is expected to accelerate study start-up and reduce study costs, as well as ensure consistency and quality of outcomes data collection across trial patients

Apr-21: Parexel and Veeva Systems announced a strategic collaboration to accelerate clinical trials through technology and process innovation. This collaboration will enhance the efficiency of clinical trials to get new therapies to patients.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1–646–491–9876